GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

New research shows that after the body's defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 ...

Laboratory services leader adds pharma veteran to board. Lab services giant LabCorp appointed Novartis US President Victor ...

Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...

AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven ...

A controversial Covid vaccine remained in use despite thousands of reports of heart conditions to the UK drug regulator, ...